Lawmakers say TikTok 'beholden' to Beijing as TikTok CEO Shou Chew testifies

Detailed updates on the high-stakes House Energy and Commerce Committee hearing.

Panacos Pharmaceuticals, Inc. (PANC)

Other OTC - Other OTC Delayed Price. Currency in USD

0.0000

(0.00%)

As of 02:02PM EDT. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.0000
Open	0.0000
Bid	0.0000 x 0
Ask	0.0000 x 0
Day's Range	0.0000 - 0.0000
52 Week Range	0.0000 - 0.0400
Volume	10
Avg. Volume	70,812

Market Cap	53
Beta (5Y Monthly)	-70.75
PE Ratio (TTM)	N/A
EPS (TTM)	-0.6670
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	3.00

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for PANC

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

PANACOS PHARMACEUTICALS INC
Market Digest: LVS, MRK, NSC, GNRC, DOCUStocks held up on March 13 after some ugly early action that saw the S&P 500 (SPX) down about 1.3%. The index rallied almost 100 points by late morning before selling off over the balance of the day. It was a great session for day traders, but created more agita for the rest of us. The morning low coincided with chart support in the 3,780-3,810 region from the late-December low. On March 14, gains were solid and broad-based.
Rating
Fair Value
Economic Moat
8 days agoArgus Research